Can Zydus Cadila's Cut-Price Enzalutamide Shake Up Indian Market?

Nearly 90% Discount To Astellas/Pfizer’s Xtandi

 
• By Vibha Ravi
  
Cost effective check approval sign concept illustration design graphic
Cadila's Generic Enzalutamide Shakes Up Current Pricing • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Business

More from Scrip